GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,172 | -10,091 | -144,172 | -138,146 | -7,521 |
| Depreciation Amortization | 7,264 | 3,073 | 4,916 | 4,793 | 1,377 |
| Other Working Capital | -581 | -534 | 1,405 | 1,873 | 1,282 |
| Other Operating Activity | 6,489 | 3,326 | 132,421 | 128,202 | 3,821 |
| Operating Cash Flow | $-6,000 | $-4,226 | $-5,430 | $-3,278 | $-1,041 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -4 | N/A | N/A |
| Investing Cash Flow | $-2 | $-2 | $-4 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,055 | 7,055 | 5,991 | 5,991 | 1,061 |
| Other Financing Activity | -533 | -533 | 0 | 0 | 0 |
| Financing Cash Flow | $6,522 | $6,522 | $5,991 | $5,991 | $1,061 |
| Beginning Cash Position | 576 | 576 | 19 | 19 | 19 |
| End Cash Position | 1,096 | 2,870 | 576 | 2,732 | 39 |
| Net Cash Flow | $520 | $2,294 | $557 | $2,713 | $20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,000 | -4,226 | -5,430 | -3,278 | -1,041 |
| Capital Expenditure | -2 | -2 | -4 | N/A | N/A |
| Free Cash Flow | -6,002 | -4,228 | -5,434 | -3,278 | -1,041 |